StockData
Seres Therapeutics, Inc. logo

Seres Therapeutics, Inc. (MCRB) stock

MCRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$1.41+0.00 (0.00%)

Close on Nov 17, 2026Market cap $14.02MP/E –Yield –

Seres Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

No gross margin figures for Seres Therapeutics

Seres Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Seres Therapeutics figures

See a number that looks wrong?